| Hepatoprotective effects of the dual peroxisome proliferator‐activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic … B Staels, A Rubenstrunk, B Noel, G Rigou, P Delataille, LJ Millatt, ... Hepatology 58 (6), 1941-1952, 2013 | 459 | 2013 |
| Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways G Chinetti-Gbaguidi, M Baron, MA Bouhlel, J Vanhoutte, C Copin, Y Sebti, ... Circulation research 108 (8), 985-995, 2011 | 448 | 2011 |
| Cell‐derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? M Baron, CM Boulanger, B Staels, A Tailleux Journal of cellular and molecular medicine 16 (7), 1365-1376, 2012 | 110 | 2012 |
| Peroxisome proliferator–activated receptor-α gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice F Lalloyer, K Wouters, M Baron, S Caron, E Vallez, J Vanhoutte, E Baugé, ... Arteriosclerosis, thrombosis, and vascular biology 31 (7), 1573-1579, 2011 | 78 | 2011 |
| Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension M Baron, J Maillet, M Huyvaert, A Dechaume, R Boutry, H Loiselle, ... Nature medicine, 1-6, 2019 | 69 | 2019 |
| Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production S Colin, O Briand, V Touche, K Wouters, M Baron, F Pattou, R Hanf, ... European heart journal 34 (32), 2566-2574, 2012 | 64 | 2012 |
| Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1α pathway K Bantubungi, SA Hannou, S Caron-Houde, E Vallez, M Baron, A Lucas, ... Diabetes 63 (10), 3199-3209, 2014 | 45 | 2014 |
| PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH M Baron, AS Leroyer, Z Majd, F Lalloyer, E Vallez, K Bantubungi, ... Atherosclerosis 218 (1), 69-76, 2011 | 38 | 2011 |
| Association study of the platelet collagen receptor glycoprotein VI gene with rheumatoid arthritis L Michou, F Cornélis, M Baron, S Bombardieri, A Balsa, R Westhovens, ... Clin. Exp. Rheumatol 31, 770-772, 2013 | 5 | 2013 |
| PPAR-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein-E2 knock-in mice F Lalloyer, K Wouters, M Baron, S Caron, E Vallez, J Vanhoutte, E Baugé, ... Arterioscler. Thromb. Vasc. Biol 31, 1573-1579, 2011 | 3 | 2011 |
| GFT505, a dual PPAR alpha/delta agonist has beneficial effects in animal models of NAFLD/NASH through PPAR alpha-dependent and independent mechanisms R Hanf, A Rubenstrunk, M Baron, R Walczak, A Tailleux, D Hum, B Staels Diabetologia 54, S510-S510, 2011 | 1 | 2011 |
| Pathogenic, loss-of function mutations in MRAP2 cause monogenic metabolic syndrome M Baron, J Maillet, M Huyvaert, A Dechaume, R Boutry, C Aubert, ... DIABETOLOGIA 62, S146-S146, 2019 | | 2019 |
| Cigarette smoking and high fat diet combination: a multi-organ approach to decipher their impact on health G Rémy, J Alard, E Dubois-Deruy, M Baron, C Grangette, F Pinet, ... European Respiratory Journal 52 (suppl 62), PA4242, 2018 | | 2018 |
| O23 Cdkn2a/p16Ink4a régule la néoglucogenèse hépatique via la voie PKA-CREB-PGC1A S Hannou, K Bantubungi-Blum, S Caron-Houde, E Vallez, M Baron, ... Diabetes & Metabolism 40, A6, 2014 | | 2014 |
| Activation of intestinal peroxisome proliferator-activated receptor-a increases high-density lipoprotein production K Wouters, M Baron, F Pattou, R Hanf European Heart Journal 34, 2566-2574, 2013 | | 2013 |
| 50 PPARA ACTIVATION DIFFERENTLY AFFECTS MICROPARTICLE CONTENT IN ATHEROSCLEROTIC LESIONS AND LIVER OF A MOUSE MODEL OF ATHEROSCLEROSIS AND NASH M Baron, AS Leroyer, Z Majd, F Lalloyer, E Vallez, K Bantubungi, ... Atherosclerosis Supplements 12 (1), 11, 2011 | | 2011 |
| PPARa gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice F Lalloyer, K Wouters, E Vallez, J Vanhoutte, M Baron, R Shiri-Sverdlov, ... Atherosclerosis Supplements 12 (1), 95-95, 2011 | | 2011 |
| PPARs, athérosclérose et stéato-hépatite non alcoolique: modulation par PPARα des concentrations en microparticules dans un modèle expérimental murin: implication de PPARϒ dans … M Baron Lille 2, 2011 | | 2011 |
